Soluble Form of Canine Transferrin Receptor Inhibits Canine Parvovirus Infection In Vitro and In Vivo
Figure 5
The effects of sTfR treatments on the morbidity (a) and mortality (b) rates of CPV-infected dogs. The dogs were treated with sTfR before CPV challenge (sTfR + CPV) and after CPV challenge (CPV + sTfR). CPV + BSA indicates the control without sTfR treatment.
